Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 410-414

  Wheat, Joe ^a,c   Marichal, Patrick ^b   Bossche, Hugo Vanden ^b   Le Monte, Ann ^a   Connolly, Patricia ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FUNGUS CULTURE; FUNGUS GROWTH; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; STEROL SYNTHESIS;

EID: 0031057821     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.410     Document Type: Article

References (15)

1. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
2. 11 phase promoting ability of sterols. FEBS Lett. 143:133-143.
3. Kersulyte, D., J. P. Woods, E. J. Keath, W. E. Goldman, and D. E. Berg. 1992. Diversity among clinical isolates of Histoplasma capsulatum detected by polymerase chain reaction with arbitrary primers. J. Bacteriol. 174:7075-7079.
4. Mahin, D. T., and R. T. Lofberg. 1966. A simplified method of sample preparation for determination of tritum, carbon 14 or sulfur 35 in blood or tissue by liquid scintillation counting. Anal. Biochem. 16:500-509.
5. Marichal, P., J. Gorrens, M.-C. Coene, L. Le Jeune, and H. Vanden Bossche. 1995. Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses 38:111-117.
6. Vanden Bossche, H., L. Koymans, and H. Moereels. 1995. P450 inhibitors of use in medical treatment: focus on mechanisms of action. Pharmacol. Ther. 67:79-100.
7. Vanden Bossche, H., P. Marichal, J. Gorrens, D. Bellen, M.-C. Coene, W. Lauwers, L. Le Jeune, H. Moereels, and P. A. J. Janssen. 1990. Mode of action of antifungals of use in immunocompromised patients, p. 223-243. In H. Vanden Bossche, D. W. R. MacKenzie, G. Cauwenbergh, J. Van Cutsem, E. Drouhet, and B. Dupont (ed.), Mycoses in AIDS patients. Plenum Press, New York, N.Y.
8. Vanden Bossche, H., P. Marichal, L. le Jeune, M.-C. Coene, J. Gorrens, and W. Cools. 1993. Effects of itraconazole on cytochrome P-450-dependent sterol 14α-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob. Agents Chemother. 37:2101-2105.
9. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
10. Wheat, J., R. Hafner, A. H. Korzun, M. T. Limjoco, P. Spencer, R. A. Larsen, F. M. Hecht, W. Powderly, and AIDS Clinical Trial Group. 1995. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 98:336-342.
11. Wheat, J., R. Hafner, M. Wulfsohn, P. Spencer, K. Squires, W. Powderly, B. Wong, M. Rinaldi, M. Saag, R. Hamill, R. Murphy, P. Connolly-Stringfield, N. Briggs, S. Owens, and NIAID Clinical Trials & Mycoses Study Group Collaborators. 1993. Prevention of relapse histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann. Intern Med. 118:610-616.
12. 11a. Wheat, J. 1996. Unpublished data.
13. Wheat, L. J., P. A. Connolly-Stringfield, R. L. Baker, M. F. Curfman, M. E. Eads, K. S. Israel, S. A. Norris, D. H. Webb, and M. L. Zeckel. 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 69:361-374.
14. Wheat, L., S. Mawhinney, R. Hafner, and D. McKinsey. 1994. Fluconazole treatment for histoplasmosis in AIDS: prospective multiccnter non-comparative trial, abstr. 1233, p. 214. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Wheat, L. J. 1996. Unpublished data.